Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch innews2026-03-24T10:41:57+00:00March 24th, 2026|Endpoints News|
Merck partners with Flagship startup Quotient to search for genetic clues to IBDnews2026-03-24T10:00:17+00:00March 24th, 2026|Endpoints News|
Liquid metal nanoparticles enable ultrafast fire detectionnews2026-03-24T08:38:00+00:00March 24th, 2026|Chemistry World|
Immutrin secures $86M for antibody programnews2026-03-24T07:00:02+00:00March 24th, 2026|Endpoints News|
